메뉴 건너뛰기




Volumn 2, Issue 5, 2017, Pages

Interruption of OX40L signaling prevents costimulation blockade–resistant allograft rejection

Author keywords

[No Author keywords available]

Indexed keywords


EID: 85029765247     PISSN: None     EISSN: 23793708     Source Type: Journal    
DOI: 10.1172/jci.insight.90317     Document Type: Article
Times cited : (13)

References (28)
  • 1
    • 20044386299 scopus 로고    scopus 로고
    • Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties
    • Larsen CP, et al. Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. Am J Transplant. 2005;5(3):443–453.
    • (2005) Am J Transplant , vol.5 , Issue.3 , pp. 443-453
    • Larsen, CP1
  • 2
    • 76949101581 scopus 로고    scopus 로고
    • A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)
    • Vincenti F, et al. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant. 2010;10(3):535–546.
    • (2010) Am J Transplant , vol.10 , Issue.3 , pp. 535-546
    • Vincenti, F1
  • 3
    • 84955444904 scopus 로고    scopus 로고
    • Belatacept and long-term outcomes in kidney transplantation
    • Vincenti F, et al. Belatacept and long-term outcomes in kidney transplantation. N Engl J Med. 2016;374(4):333–343.
    • (2016) N Engl J Med , vol.374 , Issue.4 , pp. 333-343
    • Vincenti, F1
  • 4
    • 77956528156 scopus 로고    scopus 로고
    • Five-year safety and efficacy of belatacept in renal transplantation
    • Vincenti F, et al. Five-year safety and efficacy of belatacept in renal transplantation. J Am Soc Nephrol. 2010;21(9):1587–1596.
    • (2010) J Am Soc Nephrol , vol.21 , Issue.9 , pp. 1587-1596
    • Vincenti, F1
  • 5
    • 0036664218 scopus 로고    scopus 로고
    • Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice
    • Valujskikh A, Pantenburg B, Heeger PS. Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am J Transplant. 2002;2(6):501–509.
    • (2002) Am J Transplant , vol.2 , Issue.6 , pp. 501-509
    • Valujskikh, A1    Pantenburg, B2    Heeger, PS.3
  • 6
    • 0037108492 scopus 로고    scopus 로고
    • Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients
    • Zhai Y, Meng L, Gao F, Busuttil RW, Kupiec-Weglinski JW. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients. J Immunol. 2002;169(8):4667–4673.
    • (2002) J Immunol , vol.169 , Issue.8 , pp. 4667-4673
    • Zhai, Y1    Meng, L2    Gao, F3    Busuttil, RW4    Kupiec-Weglinski, JW.5
  • 7
    • 33747500656 scopus 로고    scopus 로고
    • The impact of memory T cells on rejection and the induction of tolerance
    • Brook MO, Wood KJ, Jones ND. The impact of memory T cells on rejection and the induction of tolerance. Transplantation. 2006;82(1):1–9.
    • (2006) Transplantation , vol.82 , Issue.1 , pp. 1-9
    • Brook, MO1    Wood, KJ2    Jones, ND.3
  • 8
    • 84855943600 scopus 로고    scopus 로고
    • Integrin antagonists prevent costimulatory blockade-resistant transplant rejection by CD8(+) memory T cells
    • Kitchens WH, et al. Integrin antagonists prevent costimulatory blockade-resistant transplant rejection by CD8(+) memory T cells. Am J Transplant. 2012;12(1):69–80.
    • (2012) Am J Transplant , vol.12 , Issue.1 , pp. 69-80
    • Kitchens, WH1
  • 9
    • 84874644839 scopus 로고    scopus 로고
    • Costimulation blockade: current perspectives and implications for therapy
    • Kinnear G, Jones ND, Wood KJ. Costimulation blockade: current perspectives and implications for therapy. Transplantation. 2013;95(4):527–535.
    • (2013) Transplantation , vol.95 , Issue.4 , pp. 527-535
    • Kinnear, G1    Jones, ND2    Wood, KJ.3
  • 10
    • 59849096875 scopus 로고    scopus 로고
    • OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade
    • Burrell BE, Lu G, Li XC, Bishop DK. OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade. J Immunol. 2009;182(1):379–390.
    • (2009) J Immunol , vol.182 , Issue.1 , pp. 379-390
    • Burrell, BE1    Lu, G2    Li, XC3    Bishop, DK.4
  • 11
    • 33847152240 scopus 로고    scopus 로고
    • Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation
    • Ford ML, et al. Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation. J Exp Med. 2007;204(2):299–309.
    • (2007) J Exp Med , vol.204 , Issue.2 , pp. 299-309
    • Ford, ML1
  • 12
    • 84929000784 scopus 로고    scopus 로고
    • TIGIT and PD-1 impair tumor antigen-specific CD8+ T cells in melanoma patients
    • Chauvin JM, et al. TIGIT and PD-1 impair tumor antigen-specific CD8+ T cells in melanoma patients. J Clin Invest. 2015;125(5):2046–2058.
    • (2015) J Clin Invest , vol.125 , Issue.5 , pp. 2046-2058
    • Chauvin, JM1
  • 13
    • 84946771300 scopus 로고    scopus 로고
    • TIGIT predominantly regulates the immune response via regulatory T cells
    • Kurtulus S, et al. TIGIT predominantly regulates the immune response via regulatory T cells. J Clin Invest. 2015;125(11):4053–4062.
    • (2015) J Clin Invest , vol.125 , Issue.11 , pp. 4053-4062
    • Kurtulus, S1
  • 14
    • 0034642499 scopus 로고    scopus 로고
    • Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b
    • Bachmaier K, et al. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature. 2000;403(6766):211–216.
    • (2000) Nature , vol.403 , Issue.6766 , pp. 211-216
    • Bachmaier, K1
  • 15
    • 0028316562 scopus 로고
    • Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells
    • Croft M, Bradley LM, Swain SL. Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J Immunol. 1994;152(6):2675–2685.
    • (1994) J Immunol , vol.152 , Issue.6 , pp. 2675-2685
    • Croft, M1    Bradley, LM2    Swain, SL.3
  • 16
    • 85021389136 scopus 로고    scopus 로고
    • Alloreactive CD154-expressing T-cell subsets with differential sensitivity to the immunosuppressant, belatacept: potential targets of novel belatacept-based regimens
    • Ashokkumar C, et al. Alloreactive CD154-expressing T-cell subsets with differential sensitivity to the immunosuppressant, belatacept: potential targets of novel belatacept-based regimens. Sci Rep. 2015;5:15218.
    • (2015) Sci Rep , vol.5 , pp. 15218
    • Ashokkumar, C1
  • 17
    • 77956818277 scopus 로고    scopus 로고
    • The role of OX40 (CD134) in T-cell memory generation
    • Weinberg AD. The role of OX40 (CD134) in T-cell memory generation. Adv Exp Med Biol. 2010;684:57–68.
    • (2010) Adv Exp Med Biol , vol.684 , pp. 57-68
    • Weinberg, AD.1
  • 18
    • 31144460031 scopus 로고    scopus 로고
    • Critical, but conditional, role of OX40 in memory T cell-mediated rejection
    • Vu MD, Clarkson MR, Yagita H, Turka LA, Sayegh MH, Li XC. Critical, but conditional, role of OX40 in memory T cell-mediated rejection. J Immunol. 2006;176(3):1394–1401.
    • (2006) J Immunol , vol.176 , Issue.3 , pp. 1394-1401
    • Vu, MD1    Clarkson, MR2    Yagita, H3    Turka, LA4    Sayegh, MH5    Li, XC.6
  • 19
    • 33846399187 scopus 로고    scopus 로고
    • + memory T cell survival and significantly increases recall responses
    • + memory T cell survival and significantly increases recall responses. Eur J Immunol. 2007;37(1):157–166.
    • (2007) Eur J Immunol , vol.37 , Issue.1 , pp. 157-166
    • Ruby, CE1    Redmond, WL2    Haley, D3    Weinberg, AD.4
  • 20
    • 58749086427 scopus 로고    scopus 로고
    • OX40 costimulatory signals potentiate the memory commitment of effector CD8+ T cells
    • Mousavi SF, et al. OX40 costimulatory signals potentiate the memory commitment of effector CD8+ T cells. J Immunol. 2008;181(9):5990–6001.
    • (2008) J Immunol , vol.181 , Issue.9 , pp. 5990-6001
    • Mousavi, SF1
  • 21
    • 84911103917 scopus 로고    scopus 로고
    • Autophagy is essential for effector CD8(+) T cell survival and memory formation
    • Xu X, et al. Autophagy is essential for effector CD8(+) T cell survival and memory formation. Nat Immunol. 2014;15(12):1152–1161.
    • (2014) Nat Immunol , vol.15 , Issue.12 , pp. 1152-1161
    • Xu, X1
  • 22
    • 34948883517 scopus 로고    scopus 로고
    • + Tregs
    • + Tregs. Blood. 2007;110(7):2501–2510.
    • (2007) Blood , vol.110 , Issue.7 , pp. 2501-2510
    • Vu, MD1
  • 23
  • 24
    • 0037443415 scopus 로고    scopus 로고
    • The role of the CD134-CD134 ligand costimulatory pathway in alloimmune responses in vivo
    • Yuan X, et al. The role of the CD134-CD134 ligand costimulatory pathway in alloimmune responses in vivo. J Immunol. 2003;170(6):2949–2955.
    • (2003) J Immunol , vol.170 , Issue.6 , pp. 2949-2955
    • Yuan, X1
  • 25
    • 84897061290 scopus 로고    scopus 로고
    • Memory T cells mediate cardiac allograft vasculopathy and are inactivated by anti-OX40L monoclonal antibody
    • Wang H, et al. Memory T cells mediate cardiac allograft vasculopathy and are inactivated by anti-OX40L monoclonal antibody. Cardiovasc Drugs Ther. 2014;28(2):115–122.
    • (2014) Cardiovasc Drugs Ther , vol.28 , Issue.2 , pp. 115-122
    • Wang, H1
  • 26
    • 0142122407 scopus 로고    scopus 로고
    • Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection
    • Ehst BD, Ingulli E, Jenkins MK. Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection. Am J Transplant. 2003;3(11):1355–1362.
    • (2003) Am J Transplant , vol.3 , Issue.11 , pp. 1355-1362
    • Ehst, BD1    Ingulli, E2    Jenkins, MK.3
  • 27
    • 0036604427 scopus 로고    scopus 로고
    • Multiple mechanisms compensate to enhance tumor-protective CD8(+) T cell response in the long-term despite poor CD8(+) T cell priming initially: comparison between an acute versus a chronic intracellular bacterium expressing a model antigen
    • Dudani R, et al. Multiple mechanisms compensate to enhance tumor-protective CD8(+) T cell response in the long-term despite poor CD8(+) T cell priming initially: comparison between an acute versus a chronic intracellular bacterium expressing a model antigen. J Immunol. 2002;168(11):5737–5745.
    • (2002) J Immunol , vol.168 , Issue.11 , pp. 5737-5745
    • Dudani, R1
  • 28
    • 0142185336 scopus 로고    scopus 로고
    • Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
    • Betts MR, et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods. 2003;281(1–2):65–78.
    • (2003) J Immunol Methods , vol.281 , Issue.1–2 , pp. 65-78
    • Betts, MR1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.